Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
MPS I
Disease Information
Management of MPS I Disease
Medical Information Services
MPS I Registry
Practical Info
Request Materials
Pompe

 



 

Practical information

RIZIV/INAMI reimbursement criteria for Alduraazyme®

Click here for Dutch version (PDF)

Click here for French version (PDF)

Summary of Product Characteristics Aldurazyme®

Click here for Dutch version (PDF)
Click here for French version (PDF)

Reconstitution and Administration of Aldurazyme®

To access information about the steps required to reconstitute and administer Aldurazyme®, see Reconstitution & Administration Aldurazyme®

Medical Services

Click here to access Genzyme’s Medical Information Services

Click here to access the list of laboratories in Belgium that are known to perform testing for lysosomal storage disorders.

Click here to access the list of metabolic reference centers in Belgium.

Click here to access the list of the Centers for Human Genetics in Belgium.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with Cerezyme®

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with Fabrazyme® significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease